IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athira Pharma Inc

CUSIP: 99P19TV23 | 1 institutional holders

Quarters

Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile